Cook Medical Technologies LLC

Cook Biotech, Inc.

Coopersurgical, Inc.

Andrew P Isch

Patrick H Ruane

Benjamin T Biltz

Jeff P Little

Steven Charlebois

Keith Milner

Duane D Blatter

Zachary Wagner

Victor Havill

Kalub Hahne

Waleska Perez-Segarra

Wade Colburn

Alexander Brethauer

Peter O'Connor

Chelsea McKiernan

Gary Leung

Benjamin Blitz

Shaun A Tanner

Jeffery P Little

Erik Nevarez

A stent is provided that includes a body extending between a distal and a proximal end. The body is defined by a plurality of elongated members, with each elongated member extending between a distal end that is coterminous with the distal end of the body and a proximal end that is coterminous with the proximal end of the body. Each of the plurality of elongated members are arranged so as to define a lumen extending along the length of the respective plurality of elongated members, the lumen extending between the distal and proximal ends of the body so as to form a lumen length. Each of the plurality of elongated members are configured to permit drainage of a fluid from within the lumen to an environment external the stent along the entire lumen length.

Helical hollow strand ureteral stent

A medical device for repositioning tissue within an animal has a main body with a first end portion, a second end portion, and a middle portion. The first end portion defines a series of passageways and the second end portion defines a bulbous shape, a slot, and a tab portion. Methods of treating obstructive sleep apnea are also described.

Implantable medical devices for tissue repositioning

Described are peritoneal dialysis systems and methods that involve the use of crossflow filtration of a used dialysate withdrawn from the peritoneal space of a patient. The filtration forms a retentate containing amounts of an osmotic agent and a permeate containing amounts of water and nitrogen-containing waste products of the patient. The retentate, or a fraction thereof, can be returned to the peritoneal space of the patient to return osmotic agent to the patient. The permeate, or a fraction thereof, can be discarded to discard nitrogen-containing waste products of the patient.

Filtration system and process for peritoneal dialysis

A postpartum balloon system includes a flexible elongate catheter, an inflatable balloon, and a suction member attached to the distal end of the catheter. The system can be delivered into the uterus, where suction is applied to the suction member to anchor the balloon to the internal wall of the uterus. The catheter may include drainage ports both proximal and distal from the balloon. The system may include a stiffening stylet inserted into the drainage lumen of the catheter for aiding in delivery of the balloon. The stiffening stylet can be removed after placement of the balloon. The stiffening stylet can include side passageways that match the drainage ports and a lumen that allows for drainage through the stylet, as well as for administering drugs or other compounds through the drainage ports while the balloon is in place.

Postpartum hemorrhage balloon system

The invention relates to an antimicrobial barrier device and methods of manufacture. The antimicrobial barrier comprises one or more antimicrobial drugs that inhibit biofilm formation and bacterial and/or fungal growth. The antimicrobial barrier is suited for use with insertable devices (e.g., catheters) to reduce the incidence of infection at and around the insertion site.

Antimicrobial barrier device

The present disclosure generally provides a stent-graft for insertion into a body vessel that comprises hydrophilic polyurethane hydrogel cuffs and an elongated cylindrical body. This stent-graft exhibits an enhanced ability to maintain its original position when placed into a patient and resist the potential of migration without causing excessive discomfort to the patient. Upon exposure to bodily fluids, the cuffs of the stent-graft expand to exert a sealing or anchoring force against the wall of the body vessel. Such a stent-graft overcomes many of the problems associated with conventional stent-grafts as currently used in many different applications, for example, endovascular repair and ureteral drainage.

Hydrogel enhanced medical devices

The present invention provides an implantable medical device comprising a bioactive agent and poly(alkyl cyanoacrylate) polymer. In one embodiment of the invention, the bioactive agent is a water-soluble material, such as an antisense agent.

Implantable medical device coated with a bioactive agent

Methods of coating a medical device are provided to improve coating uniformity and reduce coating irregularities while reducing direct coating of the luminal surface of the medical device. Preferably, methods of coating a tubular medical device include the steps of: positioning the tubular medical device around a mandrel coating assembly, mounting the tubular medical device on the mandrel coating assembly and spraying a coating solution including a therapeutic agent and a solvent onto the abluminal surface of the tubular medical device mounted on the mandrel coating assembly. The mandrel coating assembly may include an axial member of a diameter that is less than the diameter of the lumen of the tubular medical device and at least one annular projection extending from the axial member to an outer surface having a diameter greater than or substantially equal to the diameter of the lumen of the medical device. Improved coating uniformity may be achieved by providing an annular space between the luminal surface of the medical device and an axial member. Coating on the luminal surface may be minimized by providing an axial member having an outer diameter that is greater than the maximum width or length of the spray contacting the axial member after passing through the openings in the medical device.

Growing community of inventors

West Lafayette, IN, United States of America

Andrew P Isch